At a glance
This program funds kidney cancer research that develops high-impact ideas to improve understanding of the disease and patient outcomes. Eligible applicants include U.S. Department of War organizations and domestic or foreign, for-profit or nonprofit organizations; investigators must be at or above assistant professor level, and awards go to organizations rather than individuals. The program expects about 8 awards, with total costs capped at $900,000 for a single-PI project or $1.2 million for the partnering-PI option, over up to 3 years. Cost sharing is not required, clinical trials are not allowed, and applications must address at least one listed kidney cancer focus area and one listed kidney cancer type.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Personnel on the proposed team should have a strong background in kidney cancer research. Distinctive Features: · Partnering Principal Investigator Option: Supports meaningful and productive partnerships between two investigators, termed the Initiating Principal Investigator (PI) and Partnering PI, collaborating on a single application. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Who can apply
- Unrestricted